The Makers & [bio] Markers Zoomcast is a fast past conversation with an Oregon Bio member.
In this zoomcast, we’ll learn how Inherent Targeting‘s new technologies will help surgeons perform better with nerve targeting imaging agents.
The Inherent Targeting company is focused on improving surgical guidance and treatment outcomes using nerve-targeted imaging agents. Currently, surgeons are entirely unassisted in nerve identification and preservation, relying solely on naked eye visualization or anatomical knowledge. Inherent Targeting’s technology provides direct highlighting of nerves during surgery in real time and is currently under clinical translation.
Panelist: Connor Barth, Ph.D., Cofounder and CEO, Inherent Targeting.